A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 126.44
GOOG 523.40
MSFT 44.40
FB 87.29
BAC 17.03

Recently Added

NNBR 25.98
CGNT 1.62
SSRG 8.68
LUV 32.51
HIBB 46.21

Gaining Speed

SSRG 8.68
HIBB 46.21
LUV 32.51
NNBR 25.98
CGNT 1.62

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!